tag:blogger.com,1999:blog-5574479.post8922728427323474740..comments2024-03-28T16:45:51.051+00:00Comments on The IPKat: Breaking news: Court of Appeal affirms "no-stay" decision in IPCom/HTC patent scrapVerónica RodrÃguez Arguijohttp://www.blogger.com/profile/05763207846940036921noreply@blogger.comBlogger5125tag:blogger.com,1999:blog-5574479.post-86306500929702345252013-11-24T14:36:13.095+00:002013-11-24T14:36:13.095+00:00Karl,
Can you give more details about these place...Karl,<br /><br />Can you give more details about these places that have pre-grant opposition?<br /><br />I am not sure what point you are trying to make.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-5574479.post-35813048379706741212013-11-24T10:14:01.383+00:002013-11-24T10:14:01.383+00:00Presumably these problems don't have happen in...Presumably these problems don't have happen in places where they have pre-grant opposition.Karlnoreply@blogger.comtag:blogger.com,1999:blog-5574479.post-26749765924755175842013-11-22T16:01:14.218+00:002013-11-22T16:01:14.218+00:00To change the EPC you need a Revision Conference (...To change the EPC you need a Revision Conference (Art 172(1) EPC) with 3/4 of the Contracting States attending and 3/4 of the attending States voting in favour of the proposed changes. Now, what are the odds of a British Judge persuading that particular herd of cats to make life easier for him?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-5574479.post-32967608705182500442013-11-22T12:03:08.383+00:002013-11-22T12:03:08.383+00:00It's probably a silly thing to say, but has an...It's probably a silly thing to say, but has anyone from the UK courts actually asked the EPO to change the opposition system so we don't have all these problems with parallel proceedings? There may be some sort of solution from the EPO side.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-5574479.post-46935332258682728962013-11-21T15:30:47.843+00:002013-11-21T15:30:47.843+00:00The most significant aspect of this decision is th...The most significant aspect of this decision is the revision of what was previously called the Glaxo guidance at para 38.Anonymousnoreply@blogger.com